Dominique Surleraux
24Patents
11h-index
23Co-inventors
67Inventor score
Filing activity: Aug 27, 2008 → May 4, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8680071B2 | Compounds and pharmaceutical compositions for the treatment of viral infections | Chemistry; Metallurgy | 54 | Active |
| US8507460B2 | Substituted 3′,5′-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections | Chemistry; Metallurgy | 48 | Active |
| US8362068B2 | 5,5-fused arylene or heteroarylene hepatitis C virus inhibitors | Chemistry; Metallurgy | 44 | Active |
| US9109001B2 | 3′,5′-cyclic phosphoramidate prodrugs for HCV infection | Chemistry; Metallurgy | 44 | Active |
| US9243025B2 | Compounds and pharmaceutical compositions for the treatment of viral infections | Chemistry; Metallurgy | 34 | Active |
| US8951985B2 | Compounds and pharmaceutical compositions for the treatment of viral infections | Human Necessities | 31 | Active |
| US7932240B2 | Phosphadiazine HCV polymerase inhibitors IV | Human Necessities | 22 | Active |
| US8193372B2 | Phosphothiophene and phosphothiazole HCV polymerase inhibitors | Chemistry; Metallurgy | 21 | Active |
| US9296778B2 | 3′,5′-cyclic phosphate prodrugs for HCV infection | Chemistry; Metallurgy | 18 | Active |
| US9309275B2 | 3′-deoxy nucleosides for the treatment of HCV | Chemistry; Metallurgy | 17 | Active |
| US9403863B2 | Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections | Chemistry; Metallurgy | 11 | Active |
| US8003659B2 | Macrocyclic serine protease inhibitors | Human Necessities | 8 | Active |
| US8377962B2 | Macrocyclic serine protease inhibitors | Chemistry; Metallurgy | 5 | Active |
| US8309737B2 | Phosphinate ruthenium complexes | Chemistry; Metallurgy | 4 | Active |
| US8481748B2 | Phosphinate ruthenium complexes | Chemistry; Metallurgy | 2 | Active |
| US8765966B2 | Phosphinate ruthenium complexes | Chemistry; Metallurgy | 1 | Active |
| US8410313B2 | Phosphinate ruthenium complexes | Chemistry; Metallurgy | 1 | Active |
| US11236093B2 | Adenine derivatives as protein kinase inhibitors | Human Necessities | 0 | Active |
| US9353100B2 | Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections | Chemistry; Metallurgy | 0 | Active |
| US9115095B2 | Phosphinate ruthenium complexes | Chemistry; Metallurgy | 0 | Active |
| US8993595B2 | Macrocyclic serine protease inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10513534B2 | 2′-chloro nucleoside analogs for HCV infection | Chemistry; Metallurgy | 0 | Active |
| US9187496B2 | 5,5-fused arylene or heteroarylene hepatitis C virus inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9284307B2 | Macrocyclic serine protease inhibitors | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.